Please login to the form below

Not currently logged in


This page shows the latest MDD news and features for those working in and with pharma, biotech and healthcare.

Depression drug failure adds to Allergan's woes

Depression drug failure adds to Allergan's woes

Axe hangs over remaining monotherapy and suicidality trials. Allergan’s novel treatment for major depressive disorder (MDD) rapastinel has failed in three pivotal phase 3 studies. ... it compared to placebo in addition to standard of care (SOC) of

Latest news

More from news
Approximately 3 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...